143 related articles for article (PubMed ID: 7829632)
1. Tamoxifen inhibits growth, migration, and invasion of human follicular and papillary thyroid cancer cells in vitro and in vivo.
Hoelting T; Siperstein AE; Duh QY; Clark OH
J Clin Endocrinol Metab; 1995 Jan; 80(1):308-13. PubMed ID: 7829632
[TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor-beta 1 is a negative regulator for differentiated thyroid cancer: studies of growth, migration, invasion, and adhesion of cultured follicular and papillary thyroid cancer cell lines.
Hölting T; Zielke A; Siperstein AE; Clark OH; Duh QY
J Clin Endocrinol Metab; 1994 Sep; 79(3):806-13. PubMed ID: 8077365
[TBL] [Abstract][Full Text] [Related]
3. Epidermal growth factor enhances proliferation, migration, and invasion of follicular and papillary thyroid cancer in vitro and in vivo.
Hoelting T; Siperstein AE; Clark OH; Duh QY
J Clin Endocrinol Metab; 1994 Aug; 79(2):401-8. PubMed ID: 8045955
[TBL] [Abstract][Full Text] [Related]
4. Somatostatin analog octreotide inhibits the growth of differentiated thyroid cancer cells in vitro, but not in vivo.
Hoelting T; Duh QY; Clark OH; Herfarth C
J Clin Endocrinol Metab; 1996 Jul; 81(7):2638-41. PubMed ID: 8675590
[TBL] [Abstract][Full Text] [Related]
5. Biphasic effects of thyrotropin on invasion and growth of papillary and follicular thyroid cancer in vitro.
Hoelting T; Tezelman S; Siperstein AE; Duh QY; Clark OH
Thyroid; 1995 Feb; 5(1):35-40. PubMed ID: 7787431
[TBL] [Abstract][Full Text] [Related]
6. [Growth and invasion in differentiated thyroid carcinoma. Function of different growth factors].
Hölting T; Duh OY; Clark OH; Herfarth C
Chirurg; 1994 Dec; 65(12):1100-6. PubMed ID: 7851142
[TBL] [Abstract][Full Text] [Related]
7. Tamoxifen antagonizes proliferation and invasion of estrogen receptor-negative metastatic follicular thyroid cancer cells via protein kinase C.
Hoelting T; Duh QY; Clark OH; Herfarth C
Cancer Lett; 1996 Feb; 100(1-2):89-93. PubMed ID: 8620458
[TBL] [Abstract][Full Text] [Related]
8. Aberrations of growth factor control in metastatic follicular thyroid cancer in vitro.
Hoelting T; Zielke A; Siperstein AE; Clark OH; Duh QY
Clin Exp Metastasis; 1994 Jul; 12(4):315-23. PubMed ID: 8039305
[TBL] [Abstract][Full Text] [Related]
9. Effects of tamoxifen and somatostatin analogue on growth of human medullary, follicular, and papillary thyroid carcinoma cell lines: tissue culture and nude mouse xenograft studies.
Weber CJ; Marvin M; Krekun S; Koschitzky T; Karp F; Benson M; Feind CR
Surgery; 1990 Dec; 108(6):1065-71. PubMed ID: 1978945
[TBL] [Abstract][Full Text] [Related]
10. Epidermal growth factor (EGF)- and transforming growth factor alpha-stimulated invasion and growth of follicular thyroid cancer cells can be blocked by antagonism to the EGF receptor and tyrosine kinase in vitro.
Hölting T; Siperstein AE; Clark OH; Duh QY
Eur J Endocrinol; 1995 Feb; 132(2):229-35. PubMed ID: 7858744
[TBL] [Abstract][Full Text] [Related]
11. [Growth and invasion of differentiated thyroid gland carcinoma: importance of signal transduction].
Hölting T; Duh OY; Clark OH; Herfarth C
Langenbecks Arch Chir; 1995; 380(2):96-101. PubMed ID: 7760657
[TBL] [Abstract][Full Text] [Related]
12. Papillary and follicular variant of papillary carcinoma of the thyroid: Initial presentation and response to therapy.
Burningham AR; Krishnan J; Davidson BJ; Ringel MD; Burman KD
Otolaryngol Head Neck Surg; 2005 Jun; 132(6):840-4. PubMed ID: 15944551
[TBL] [Abstract][Full Text] [Related]
13. Testosterone and estradiol have specific differential modulatory effect on the proliferation of human thyroid papillary and follicular carcinoma cell lines independent of TSH action.
Banu KS; Govindarajulu P; Aruldhas MM
Endocr Pathol; 2001; 12(3):315-27. PubMed ID: 11740053
[TBL] [Abstract][Full Text] [Related]
14. The heat shock protein 90-binding geldanamycin inhibits cancer cell proliferation, down-regulates oncoproteins, and inhibits epidermal growth factor-induced invasion in thyroid cancer cell lines.
Park JW; Yeh MW; Wong MG; Lobo M; Hyun WC; Duh QY; Clark OH
J Clin Endocrinol Metab; 2003 Jul; 88(7):3346-53. PubMed ID: 12843186
[TBL] [Abstract][Full Text] [Related]
15. Anti-thyroid cancer properties of a novel isoflavone derivative, 7-(O)-carboxymethyl daidzein conjugated to N-t-Boc-hexylenediamine in vitro and in vivo.
Somjen D; Grafi-Cohen M; Katzburg S; Weisinger G; Izkhakov E; Nevo N; Sharon O; Kraiem Z; Kohen F; Stern N
J Steroid Biochem Mol Biol; 2011 Sep; 126(3-5):95-103. PubMed ID: 21600982
[TBL] [Abstract][Full Text] [Related]
16. A new antiestrogen, 2-(4-hydroxy-phenyl)-3-methyl-1-[4-(2-piperidin-1-yl-ethoxy)-benzyl]-1H-indol-5-ol hydrochloride (ERA-923), inhibits the growth of tamoxifen-sensitive and -resistant tumors and is devoid of uterotropic effects in mice and rats.
Greenberger LM; Annable T; Collins KI; Komm BS; Lyttle CR; Miller CP; Satyaswaroop PG; Zhang Y; Frost P
Clin Cancer Res; 2001 Oct; 7(10):3166-77. PubMed ID: 11595711
[TBL] [Abstract][Full Text] [Related]
17. Shikonin inhibits thyroid cancer cell growth and invasiveness through targeting major signaling pathways.
Yang Q; Ji M; Guan H; Shi B; Hou P
J Clin Endocrinol Metab; 2013 Dec; 98(12):E1909-17. PubMed ID: 24106286
[TBL] [Abstract][Full Text] [Related]
18. Effect on growth and cell cycle kinetics of estradiol and tamoxifen on MCF-7 human breast cancer cells grown in vitro and in nude mice.
Brünner N; Bronzert D; Vindeløv LL; Rygaard K; Spang-Thomsen M; Lippman ME
Cancer Res; 1989 Mar; 49(6):1515-20. PubMed ID: 2924304
[TBL] [Abstract][Full Text] [Related]
19. Tamoxifen-mediated growth inhibition of human cholangiocarcinoma.
Sampson LK; Vickers SM; Ying W; Phillips JO
Cancer Res; 1997 May; 57(9):1743-9. PubMed ID: 9135018
[TBL] [Abstract][Full Text] [Related]
20. An orthotopic model of papillary thyroid carcinoma in athymic nude mice.
Ahn SH; Henderson Y; Kang Y; Chattopadhyay C; Holton P; Wang M; Briggs K; Clayman GL
Arch Otolaryngol Head Neck Surg; 2008 Feb; 134(2):190-7. PubMed ID: 18283163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]